The role of placental growth factor as a biomarker in patients with resectable gastric cancer

Background - Systemic treatment failure and an insufficient treatment response to neoadjuvant treatment underscore the urgency for better tumor-directed treatment for patients with resectable gastric cancer. The angiogenic pathway has repeatedly shown predictive and prognostic value in this cancer s...

Full description

Saved in:
Bibliographic Details
Main Authors: Rompen, Ingmar F. (Author) , Nerz, Daniel (Author) , Crnovrsanin, Nerma (Author) , Hu, Wenjun (Author) , Zimmer, Sarah (Author) , Musa, Julian (Author) , Haag, Georg Martin (Author) , Fiedler, Timon (Author) , Longerich, Thomas (Author) , Saeedi, Mohammed al (Author) , Peters, Leila (Author) , Schmidt, Thomas (Author) , Nienhüser, Henrik (Author)
Format: Article (Journal)
Language:English
Published: June 2025
In: Journal of gastrointestinal surgery
Year: 2025, Volume: 29, Issue: 6, Pages: 1-7
ISSN:1873-4626
DOI:10.1016/j.gassur.2025.102051
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.gassur.2025.102051
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1091255X25001106
Get full text
Author Notes:Ingmar F. Rompen, Daniel Nerz, Nerma Crnovrsanin, Wenjun Hu, Sarah Zimmer, Julian Musa, Georg Martin Haag, Timon Fiedler, Thomas Longerich, Mohammed Al-Saeedi, Leila Sisic, Thomas Schmidt, Henrik Nienhüser

MARC

LEADER 00000caa a2200000 c 4500
001 1940894646
003 DE-627
005 20251120193726.0
007 cr uuu---uuuuu
008 251111s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.gassur.2025.102051  |2 doi 
035 |a (DE-627)1940894646 
035 |a (DE-599)KXP1940894646 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rompen, Ingmar F.  |d 1994-  |e VerfasserIn  |0 (DE-588)1260414086  |0 (DE-627)1807281671  |4 aut 
245 1 4 |a The role of placental growth factor as a biomarker in patients with resectable gastric cancer  |c Ingmar F. Rompen, Daniel Nerz, Nerma Crnovrsanin, Wenjun Hu, Sarah Zimmer, Julian Musa, Georg Martin Haag, Timon Fiedler, Thomas Longerich, Mohammed Al-Saeedi, Leila Sisic, Thomas Schmidt, Henrik Nienhüser 
264 1 |c June 2025 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 3. April 2025, Artikelversion: 16. April 2025 
500 |a Gesehen am 11.11.2025 
520 |a Background - Systemic treatment failure and an insufficient treatment response to neoadjuvant treatment underscore the urgency for better tumor-directed treatment for patients with resectable gastric cancer. The angiogenic pathway has repeatedly shown predictive and prognostic value in this cancer subtype; however, the relevance of placental growth factor (PlGF) is unclear. Therefore, we aimed to assess PlGF as a prognostic and predictive biomarker. - Methods - This translational study was performed in 2 phases. First, adenogastric (AGS) and Mie-Kinen-45 (MKN-45) gastric cancer cell lines were treated with recombinant angiogenic growth factors and chemotherapeutic agents. Cell count analyses and quantitative polymerase chain reaction were performed to assess proliferative and cytotoxic effects. Second, prospectively collected blood samples of patients undergoing surgical treatment for gastric cancer were assessed by enzyme-linked immunosorbent assay and correlated to clinicopathologic outcomes. - Results - In MKN-45 cells, treatment with PlGF led to increased cell numbers after 72 h (P <.01), whereas proliferative effects of PlGF were less pronounced in the AGS cell line. Addition of PlGF lowered the cytotoxic effect of standard chemotherapeutic agents as evidenced by significant differences in cell growth at low concentrations of cisplatin (5 µM cisplatin vs 5 µM cisplatin plus PlGF) and high concentrations of paclitaxel (25 µM paclitaxel vs 25 µM paclitaxel plus PlGF) in both AGS and MKN-45 cell cultures after 72 h (all comparisons P <.05). In patients with gastric cancer (n = 68), high PlGF concentrations were significantly associated with more recurrences (estimated 5-year-recurrence rate, 34% [high PlGF] vs 6% [low PlGF]; log-rank P =.009) but no association was found with pathologic treatment response, tumor size, nodal stage, or tumor grade. - Conclusion - The association of elevated PlGF expression with disease-specific survival despite no correlation with other tumor-specific prognostic factors may indicate that PlGF could be used as an independent prognostic biomarker in gastric cancer. The ability to predict resistance to neoadjuvant treatment, as demonstrated in cell experiments, requires further investigation in a clinical setting. 
650 4 |a Biomarker 
650 4 |a Gastric neoplasm 
650 4 |a Neoadjuvant treatment 
650 4 |a Placental growth factor 
650 4 |a Surgical oncology 
700 1 |a Nerz, Daniel  |d 1992-  |e VerfasserIn  |0 (DE-588)1224836464  |0 (DE-627)1744315183  |4 aut 
700 1 |a Crnovrsanin, Nerma  |e VerfasserIn  |0 (DE-588)1224835220  |0 (DE-627)174431442X  |4 aut 
700 1 |a Hu, Wenjun  |e VerfasserIn  |0 (DE-588)1379664047  |0 (DE-627)1939328543  |4 aut 
700 1 |a Zimmer, Sarah  |e VerfasserIn  |0 (DE-588)1378680995  |0 (DE-627)1938232658  |4 aut 
700 1 |a Musa, Julian  |d 1992-  |e VerfasserIn  |0 (DE-588)1218049243  |0 (DE-627)1733515569  |4 aut 
700 1 |a Haag, Georg Martin  |d 1979-  |e VerfasserIn  |0 (DE-588)133390934  |0 (DE-627)544043863  |0 (DE-576)29981548X  |4 aut 
700 1 |a Fiedler, Timon  |d 1993-  |e VerfasserIn  |0 (DE-588)1298973546  |0 (DE-627)1855143542  |4 aut 
700 1 |a Longerich, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)128494514  |0 (DE-627)373916124  |0 (DE-576)297178059  |4 aut 
700 1 |a Saeedi, Mohammed al  |d 1981-  |e VerfasserIn  |0 (DE-588)1046246933  |0 (DE-627)776004999  |0 (DE-576)399532498  |4 aut 
700 1 |a Peters, Leila  |d 1982-  |e VerfasserIn  |0 (DE-588)1031408770  |0 (DE-627)736378405  |0 (DE-576)378855654  |4 aut 
700 1 |a Schmidt, Thomas  |d 1980-  |e VerfasserIn  |0 (DE-588)132383152  |0 (DE-627)521950023  |0 (DE-576)260799149  |4 aut 
700 1 |a Nienhüser, Henrik  |d 1986-  |e VerfasserIn  |0 (DE-588)104690342X  |0 (DE-627)777295865  |0 (DE-576)398176477  |4 aut 
773 0 8 |i Enthalten in  |t Journal of gastrointestinal surgery  |d [Amsterdam] : Elsevier, 1997  |g 29(2025), 6 vom: Juni, Artikel-ID 102051, Seite 1-7  |h Online-Ressource  |w (DE-627)334375053  |w (DE-600)2057634-1  |w (DE-576)25644224X  |x 1873-4626  |7 nnas  |a The role of placental growth factor as a biomarker in patients with resectable gastric cancer 
773 1 8 |g volume:29  |g year:2025  |g number:6  |g month:06  |g elocationid:102051  |g pages:1-7  |g extent:7  |a The role of placental growth factor as a biomarker in patients with resectable gastric cancer 
856 4 0 |u https://doi.org/10.1016/j.gassur.2025.102051  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1091255X25001106  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251111 
993 |a Article 
994 |a 2025 
998 |g 104690342X  |a Nienhüser, Henrik  |m 104690342X:Nienhüser, Henrik  |d 910000  |d 910200  |e 910000PN104690342X  |e 910200PN104690342X  |k 0/910000/  |k 1/910000/910200/  |p 12 
998 |g 132383152  |a Schmidt, Thomas  |m 132383152:Schmidt, Thomas  |d 50000  |e 50000PS132383152  |k 0/50000/  |p 11 
998 |g 1031408770  |a Peters, Leila  |m 1031408770:Peters, Leila  |d 910000  |d 910200  |d 50000  |e 910000PP1031408770  |e 910200PP1031408770  |e 50000PP1031408770  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 10 
998 |g 1046246933  |a Saeedi, Mohammed al  |m 1046246933:Saeedi, Mohammed al  |d 910000  |d 910200  |e 910000PS1046246933  |e 910200PS1046246933  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 128494514  |a Longerich, Thomas  |m 128494514:Longerich, Thomas  |d 910000  |d 912000  |e 910000PL128494514  |e 912000PL128494514  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 1298973546  |a Fiedler, Timon  |m 1298973546:Fiedler, Timon  |d 910000  |d 912000  |e 910000PF1298973546  |e 912000PF1298973546  |k 0/910000/  |k 1/910000/912000/  |p 7 
998 |g 133390934  |a Haag, Georg Martin  |m 133390934:Haag, Georg Martin  |d 910000  |d 910100  |d 50000  |e 910000PH133390934  |e 910100PH133390934  |e 50000PH133390934  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 1378680995  |a Zimmer, Sarah  |m 1378680995:Zimmer, Sarah  |d 910000  |d 910200  |e 910000PZ1378680995  |e 910200PZ1378680995  |k 0/910000/  |k 1/910000/910200/  |p 5 
998 |g 1379664047  |a Hu, Wenjun  |m 1379664047:Hu, Wenjun  |d 50000  |e 50000PH1379664047  |k 0/50000/  |p 4 
998 |g 1224835220  |a Crnovrsanin, Nerma  |m 1224835220:Crnovrsanin, Nerma  |d 910000  |d 910200  |e 910000PC1224835220  |e 910200PC1224835220  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1260414086  |a Rompen, Ingmar F.  |m 1260414086:Rompen, Ingmar F.  |d 910000  |d 910200  |e 910000PR1260414086  |e 910200PR1260414086  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1940894646  |e 4802229828 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ingmar F. Rompen, Daniel Nerz, Nerma Crnovrsanin, Wenjun Hu, Sarah Zimmer, Julian Musa, Georg Martin Haag, Timon Fiedler, Thomas Longerich, Mohammed Al-Saeedi, Leila Sisic, Thomas Schmidt, Henrik Nienhüser"]},"recId":"1940894646","note":["Online verfügbar: 3. April 2025, Artikelversion: 16. April 2025","Gesehen am 11.11.2025"],"language":["eng"],"id":{"doi":["10.1016/j.gassur.2025.102051"],"eki":["1940894646"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"person":[{"role":"aut","given":"Ingmar F.","family":"Rompen","display":"Rompen, Ingmar F."},{"role":"aut","display":"Nerz, Daniel","family":"Nerz","given":"Daniel"},{"role":"aut","display":"Crnovrsanin, Nerma","family":"Crnovrsanin","given":"Nerma"},{"role":"aut","family":"Hu","display":"Hu, Wenjun","given":"Wenjun"},{"display":"Zimmer, Sarah","family":"Zimmer","given":"Sarah","role":"aut"},{"role":"aut","family":"Musa","display":"Musa, Julian","given":"Julian"},{"role":"aut","family":"Haag","display":"Haag, Georg Martin","given":"Georg Martin"},{"display":"Fiedler, Timon","family":"Fiedler","given":"Timon","role":"aut"},{"role":"aut","given":"Thomas","family":"Longerich","display":"Longerich, Thomas"},{"given":"Mohammed al","family":"Saeedi","display":"Saeedi, Mohammed al","role":"aut"},{"role":"aut","display":"Peters, Leila","family":"Peters","given":"Leila"},{"display":"Schmidt, Thomas","family":"Schmidt","given":"Thomas","role":"aut"},{"given":"Henrik","display":"Nienhüser, Henrik","family":"Nienhüser","role":"aut"}],"title":[{"title":"The role of placental growth factor as a biomarker in patients with resectable gastric cancer","title_sort":"role of placental growth factor as a biomarker in patients with resectable gastric cancer"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1873-4626"],"zdb":["2057634-1"],"eki":["334375053"]},"language":["eng"],"origin":[{"dateIssuedKey":"2024","publisher":"Elsevier ; Elsevier Science ; Springer","publisherPlace":"[Amsterdam] ; Amsterdam [u.a.] ; New York, NY","dateIssuedDisp":"2024-"}],"part":{"volume":"29","pages":"1-7","text":"29(2025), 6 vom: Juni, Artikel-ID 102051, Seite 1-7","year":"2025","extent":"7","issue":"6"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"official journal of the Society for Surgery of the Alimentary Tract and the American Hepato-Pancreato-Biliary Association","title":"Journal of gastrointestinal surgery","title_sort":"Journal of gastrointestinal surgery"}],"disp":"The role of placental growth factor as a biomarker in patients with resectable gastric cancerJournal of gastrointestinal surgery","pubHistory":["1.1997 -"],"note":["Gesehen am 25.01.24"],"recId":"334375053"}]} 
SRT |a ROMPENINGMROLEOFPLAC2025